Economic analysis of the use of recombinant human granulocyte colony stimulating factor in autologous bone marrow transplantation.

Abstract

The aim of this study was to assess the economic impact of the use of granulocyte colony stimulating factor (RHu-G-CSF) in patients treated by autologous bone marrow transplantation (ABMT) for lymphomas. Demographic, clinical and economic data were collected retrospectively from a random sample of 55 patients in four French centres who underwent ABMT (usual… (More)

Topics

  • Presentations referencing similar topics